Finally, our study revealed the direct effect of the β2-adrenergic receptor agonist and antagonist on IL-17 and IFN-γ production by stimulated CD4+ T cells and PBMCs in MS patients and healthy subjects. Here, IL17A is linked to myeloid sarcoma.